Morphic Therapeutic (MORF) Announces Proposed Public Offering

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/12/2026

1. PLTR
2. SPY
3. KTOS
4. MSFT
5. AON
6. TMUS
7. LBRX
8. BMY
9. MRK
10. TRAX

Go back to Morphic Therapeutic (MORF) Announces Proposed Public Offering

Morphic Therapeutic Announces Proposed Public Offering

May 2, 2023 4:02 PM EDT

WALTHAM, Mass., May 02, 2023 (GLOBE NEWSWIRE) -- Morphic Holding, Inc. (Nasdaq: MORF), a biopharmaceutical company developing a portfolio of oral integrin therapies for the treatment of serious chronic diseases, today announced a proposed underwritten public offering of its common stock. In addition, Morphic intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of its common stock offered in the offering. All of the shares of common stock are being offered by Morphic. The offering is subject to market and other conditions,... More